A novel pyrazolo[3,4-d]pyrimidin-4-one derivatives with quinoline scaffold (18a-d) was found to have dual potent PDE5 inhibitory activity (e.g. IC50 of 18c = 1.57 nM) and apoptosis induction in several types of cancer cells. This evidence concerns the gene PDE5A and cancer.